Aestus Therapeutics Inc. Awarded Qualifying Therapeutic Development Project Grant for Clinical Studies of Novel Pain Treatment

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Today Aestus Therapeutics, Inc. announced that it has been awarded a $244,000 grant from the U.S. Government's Qualifying Therapeutic Discovery Project ("QTDP") program. The grant, awarded for the project, “Treating neuropathic pain by means of novel mechanisms,” will help to fund clinical trials of Aestus’s novel, first-in-class treatment for chronic neuropathic pain.